RA

Royce & Associates Portfolio holdings

AUM $12.4B Turnover 20.64%
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+28.76%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$12.4B
AUM Growth
+$2.29B
Cap. Flow
-$8.07M
Cap. Flow %
-0.07%
Top 10 Hldgs %
9.07%
Holding
848
New
74
Increased
361
Reduced
233
Closed
101
Avg Time Held
4.5 years
Top 10 Avg Time Held
0.8 years
Top 20 Avg Time Held
1.8 years

Top Buys

Rank Stock Value
1
MANH icon
Manhattan Associates
MANH
+$43.3M
2
MSA icon
Mine Safety
MSA
+$37.1M
3
YSWY icon
Yesway Inc
YSWY
+$34.7M
4
DORM icon
Dorman Products
DORM
+$24.6M
5
AVTR icon
Avantor
AVTR
+$19M

Top Sells

Rank Stock Value
1
COHU icon
Cohu
COHU
+$54.5M
2
CPRX icon
Catalyst Pharmaceutical
CPRX
+$51.1M
3
MKSI icon
MKS Inc
MKSI
+$44.5M
4
VSH icon
Vishay Intertechnology
VSH
+$40.2M
5
LFUS icon
Littelfuse
LFUS
+$35.4M

Sector Composition

Rank Sector Weight
1 Industrials 26.88%
2 Technology 19.45%
3 Financials 14.84%
4 Consumer Discretionary 12.86%
5 Healthcare 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ODC icon
526
Oil-Dri
ODC
$1.24B
$4.14M 0.03%
40,532
-72,782
-64% -$5.82M
2023 Q2
12 quarters
CIX icon
527
Comp X International
CIX
$454M
$4.14M 0.03%
166,074
– –
2013 Q2
52 quarters
WSBC icon
528
WesBanco
WSBC
$3.5B
$4.13M 0.03%
105,847
+6,555
+7% +$231K
2025 Q1
5 quarters
HLI icon
529
Houlihan Lokey
HLI
$8.72B
$4.09M 0.03%
30,495
-6,184
-17% -$912K
2016 Q3
39 quarters
DHX icon
530
DHI Group
DHX
$213M
$4.08M 0.03%
1,098,945
+291,303
+36% +$962K
2021 Q2
20 quarters
AGX icon
531
Argan
AGX
$5.13B
$3.99M 0.03%
4,994
-31,486
-86% -$20.9M
2022 Q4
14 quarters
LNC icon
532
Lincoln National
LNC
$7.7B
$3.97M 0.03%
112,377
+65,807
+141% +$2.37M
2024 Q3
7 quarters
BHRB icon
533
Burke & Herbert Financial Services Corp
BHRB
$1.38B
$3.95M 0.03%
54,973
-4,129
-7% -$267K
2024 Q2
8 quarters
DGICA icon
534
Donegal Group Class A
DGICA
$675M
$3.95M 0.03%
209,183
+11,208
+6% +$195K
2025 Q3
3 quarters
XENE icon
535
Xenon Pharmaceuticals
XENE
$3.28B
$3.93M 0.03%
+65,032
New +$3.61M
2026 Q2
0 quarters
BPRN icon
536
Princeton Bancorp
BPRN
$295M
$3.81M 0.03%
100,389
+19,919
+25% +$713K
2022 Q1
17 quarters
CMPS icon
537
Compass Pathways
CMPS
$1.56B
$3.78M 0.03%
267,059
-115,027
-30% -$1.17M
2026 Q1
1 quarter
MCY icon
538
Mercury Insurance
MCY
$5.67B
$3.76M 0.03%
35,263
+12,983
+58% +$1.28M
2024 Q4
6 quarters
HCC icon
539
Warrior Met Coal
HCC
$4.75B
$3.74M 0.03%
+46,072
New +$4.17M
2026 Q2
0 quarters
LAB icon
540
Standard BioTools
LAB
$248M
$3.72M 0.03%
4,525,333
+1,519,804
+51% +$1.44M
2024 Q2
8 quarters
MPB icon
541
Mid Penn Bancorp
MPB
$900M
$3.71M 0.03%
106,457
+6,148
+6% +$204K
2022 Q1
17 quarters
GILD icon
542
Gilead Sciences
GILD
$190B
$3.66M 0.03%
29,000
– –
2022 Q1
17 quarters
FFBC icon
543
First Financial Bancorp
FFBC
$3.24B
$3.66M 0.03%
108,149
+542
+0.5% +$16.6K
2024 Q1
9 quarters
XERS icon
544
Xeris Biopharma Holdings
XERS
$1.78B
$3.65M 0.03%
461,153
+205,066
+80% +$1.31M
2026 Q1
1 quarter
OII icon
545
Oceaneering
OII
$4.33B
$3.65M 0.03%
90,020
+7,003
+8% +$264K
2021 Q4
18 quarters
GRDN icon
546
Guardian Pharmacy Services
GRDN
$2.57B
$3.65M 0.03%
87,096
– –
2024 Q3
7 quarters
HAFC icon
547
Hanmi Financial
HAFC
$904M
$3.64M 0.03%
112,484
-679
-0.6% -$20.3K
2017 Q3
35 quarters
SNA icon
548
Snap-on
SNA
$18.8B
$3.62M 0.03%
9,000
– –
2021 Q4
18 quarters
ARES icon
549
Ares Management
ARES
$25.6B
$3.54M 0.03%
31,800
– –
2015 Q2
44 quarters
RDN icon
550
Radian Group
RDN
$4.42B
$3.51M 0.03%
93,191
+1,417
+2% +$50.3K
2023 Q2
12 quarters
20 21
22
23 24

Similar funds

JF
Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $12.5B AUM 306.52% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
LC
Loews Corp New York $12.5B AUM 4.69% 1-Year Est. Return
AIM
Adapt Investment Managers Geneva, Switzerland $12.6B AUM 11.86% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $12.6B AUM 31.26% 1-Year Est. Return
BAMF
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $12.6B AUM 41.69% 1-Year Est. Return

Royce & Associates's Q2 2026 Portfolio in Review

As of Q2 2026, Royce & Associates held 848 positions worth $12.4B, up 23% from $10.1B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.

Royce & Associates's Q2 2026 filing shows 74 new, 361 increased, 233 reduced and 101 closed positions. Its largest new stake was Manhattan Associates: 314,304 shares worth $43.8M. The largest sale was Cohu, an estimated $54.5M.

By sector, the portfolio is most concentrated in Industrials at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.

  • Royce & Associates's largest Q2 2026 buy was Manhattan Associates: 314,304 shares worth $43.8M.
  • Royce & Associates added most to Mine Safety in Q2 2026, an estimated $37.1M increase.
  • Royce & Associates's biggest Q2 2026 reduction was Cohu, cutting an estimated $54.5M.
  • Royce & Associates fully exited Transmedics in Q2 2026, selling an estimated $24.3M.
  • Royce & Associates's ten largest holdings make up 9.1% of its $12.4B portfolio in Q2 2026.
  • Royce & Associates opened 74 new positions and closed 101 in Q2 2026.
  • Royce & Associates's portfolio value rose 23% quarter-over-quarter to $12.4B.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.